Ironwood Pharmaceuticals (IRWD) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to 0.67.
- Ironwood Pharmaceuticals' Equity Ratio rose 1655.49% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year increase of 1655.49%. This contributed to the annual value of 0.86 for FY2024, which is 1681.49% down from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Equity Ratio of 0.67 as of Q3 2025, which was up 1655.49% from 0.9 recorded in Q2 2025.
- Ironwood Pharmaceuticals' 5-year Equity Ratio high stood at 0.61 for Q1 2023, and its period low was 1.02 during Q1 2025.
- In the last 5 years, Ironwood Pharmaceuticals' Equity Ratio had a median value of 0.57 in 2023 and averaged 0.17.
- As far as peak fluctuations go, Ironwood Pharmaceuticals' Equity Ratio skyrocketed by 438040.97% in 2021, and later tumbled by 22400.99% in 2023.
- Ironwood Pharmaceuticals' Equity Ratio (Quarter) stood at 0.54 in 2021, then rose by 10.25% to 0.59 in 2022, then crashed by 224.01% to 0.74 in 2023, then fell by 16.81% to 0.86 in 2024, then increased by 22.33% to 0.67 in 2025.
- Its Equity Ratio was 0.67 in Q3 2025, compared to 0.9 in Q2 2025 and 1.02 in Q1 2025.